Jiangsu Apon Medical Technology Co Ltd Class A Capital Reinvestment Ratio

Latest as of December 2024: 0.11x

Jiangsu Apon Medical Technology Co Ltd Class A capital reinvestment ratio. Jiangsu Apon Medical Technology Co Ltd Class A (300753) has a Capital Reinvestment Ratio of 0.11x as of December 2024, meaning it reinvests 0% of its operating cash flow (CN¥49.02 Million) in capital expenditures (CN¥5.48 Million). Check 300753 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.11x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥49.02 Million
CNY

Capital Expenditures

CN¥5.48 Million
CNY

Data as of

Dec 2024
Most recent filing

Capital Reinvestment Ratio of Jiangsu Apon Medical Technology Co Ltd Class A (2014–2024)

Capital reinvestment ratio of Jiangsu Apon Medical Technology Co Ltd Class A from 2014 to 2024. This chart tracks Jiangsu Apon Medical Technology Co Ltd Class A's Capital Reinvestment Ratio across 9 annual periods. Also explore 300753 net assets growth trend to track the company's year-over-year net asset growth rate.

Jiangsu Apon Medical Technology Co Ltd Class A Capital Reinvestment Ratio by Year (2014–2024)

Jiangsu Apon Medical Technology Co Ltd Class A capital reinvestment ratio by year from 2014 to 2024. For the full cash flow conversion analysis, see cash flow conversion of Jiangsu Apon Medical Technology Co Ltd C.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2024 0.65x CN¥15.68 Million CN¥10.23 Million ▼ -69.9%
2021 2.17x CN¥18.29 Million CN¥39.60 Million ▲ +406.5%
2020 0.43x CN¥83.34 Million CN¥35.64 Million ▼ -43.1%
2019 0.75x CN¥77.59 Million CN¥58.33 Million ▼ -4.6%
2018 0.79x CN¥78.13 Million CN¥61.59 Million ▲ +237.5%
2017 0.23x CN¥67.08 Million CN¥15.66 Million ▲ +229.1%
2016 0.07x CN¥60.97 Million CN¥4.33 Million ▼ -12.8%
2015 0.08x CN¥38.08 Million CN¥3.10 Million ▲ +2.4%
2014 0.08x CN¥33.49 Million CN¥2.66 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow